Jan Hendrik Frenking
8PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 13, 2026
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.Jan H Frenking, Christine Riedhammer, Thomas Hielscher
|Dec 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.Martin Grözinger, Muriel Schlanke, Jana Gröne
|Jul 11, 2025
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.Tim Richardson, Udo Holtick, Jan-Hendrik Frenking
|Apr 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.Jan H Frenking, Xiang Zhou, Kai Rejeski
|Apr 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.Jan H Frenking, Christine Riedhammer, Raphael Teipel
|Oct 08, 2024
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.Jan H Frenking, Xiang Zhou, Vivien Wagner
Pageof 2
Frequent Collaborators
4 joint publications
Elias K Mai
4 joint publications
Marc S Raab
4 joint publications
Carsten Müller-Tidow
3 joint publications
Hartmut Goldschmidt
2 joint publications
Tim Richardson
2 joint publications
Lilli Sophie Sester
2 joint publications
Leo Rasche
2 joint publications
Sandra Sauer
2 joint publications
Christian S Michel
2 joint publications
Niels Weinhold
